Discovery of a cholecystokinin analogue with partial agonist activity
- 1 September 1984
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 247 (3) , G261-G264
- https://doi.org/10.1152/ajpgi.1984.247.3.g261
Abstract
In dispersed acini from guinea pig pancreas, cholecystokinin-(27-32)-amide [CCK-(27-32)-NH2] did not stimulate amylase secretion and inhibited the stimulation caused by CCK-(26-33). In dispersed acini from mouse or rat pancreas, CCK-(27-32)-NH2 stimulated amylase secretion. The stimulation of amylase secretion caused by a maximally effective concentration of CCK-(27-32)-NH2 was less than that caused by a maximally effective concentration of cholecystokinin-(26-33), and in contrast to the action of cholecystokinin-(26-33) supramaximal concentrations of CCK-(27-32)-NH2 did not cause submaximal stimulation of amylase secretion. Dibutyryl cGMP and proglumide each inhibited the stimulation of amylase secretion caused by CCK-(27-32)-NH2. CCK-(27-32)-NH2 inhibited binding of 125I-labeled CCK to mouse and rat pancreatic acini. These results indicate that, in mouse and rat pancreatic acini, CCK-(27-32)-NH2 is a partial agonist and that this partial agonist activity is produced by occupation of the CCK receptor by CCK-(27-32)-NH2.This publication has 2 references indexed in Scilit:
- COOH-terminal fragments of cholecystokinin a new class of cholecystokinin receptor antagonistsBiochimica et Biophysica Acta (BBA) - General Subjects, 1983
- Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cellsProceedings of the National Academy of Sciences, 1980